The Toronto-based medical device firm will present its cleared hybrid intravascular imaging platform at TCT 2026 in San Diego, marking its first appearance since

Radial Arterial Catheters: How standardization, ultrasound guidance, and evidence-based practices are redefining critical care.

CV Ultrasound Clinical Solution Consultant Manager - Midwest Zone at Philips Careers in United States of America - Home Based, United States · Omaha, Nebraska, United States · Kansas City, Missouri, United States · Wichita, Kansas, United States · Minneapolis, Minnesota, United States · Detroit, Michigan, United States · Louisville, Kentucky, United States · Columbus, Ohio, United Stat. View details and apply on the employer website.

UK-based OxSonics was founded to solve one of the most persistent challenges in oncology: getting drugs to where they are needed inside solid tumours. Using technology that originated within Oxford University’s Institute of Biomedical Engineering, the company aims to enhance drug delivery to solid tumors. We recently spoke with the company’s CEO Jérôme Marzinski about OxSonics’ mission ...

Barium titanate-based materials serve as highly efficient catalysts in the realm of piezoelectric ceramics. With the aid of ultrasound, these piezoelectric ceramics have been widely used and exhibit…

APL researchers are developing OsteoSEE, an ultrasound-based technology that uses surface acoustic waves to detect early-stage tibial stress fractures, with the potential to support earlier interventi...

Johns Hopkins Applied Physics Laboratory researchers are developing OsteoSEE, an ultrasound-based technology that uses surface acoustic waves to detect early-stage tibial stress fractures, with the…

Study in Radiology shows an injection around pinched nerve offers longer-lasting relief than cortisone A treatment using saline and ultrasound, without surgery, appears to be able to provide longer-lasting relief for patients with carpal tunnel syndromeaccording to a new scientific study. The method is based on releasing the nerve that is pressed on the wrist by injecting fluid around it.

RIVANNA announced on October 22, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for BoneEnhance, a machine learning software module for the company’s Accuro XV diagnostic ultrasound system. The module segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions during image review. The Charlottesville, Virginia-based company, which develops AI-enabled clinical decision-support systems, described BoneEnhance as the first machine learning software module cleared for the Accuro XV platform. RIVANNA framed the clearance as moving the platform from acquisition toward interpretation: the Accuro XV performs the volumetric image acquisition, and BoneEnhance labels the anatomy captured within it. The underlying system was cleared in April 2026 for B-mode imaging in musculoskeletal conventional and superficial applications, according to the release; RIVANNA publicly announced that earlier clearance on May 7, 2026. How BoneEnhance Works on the Accuro XV Each automated Accuro XV acquisition produces a volumetric dataset for review. Within that volume, BoneEnhance identifies bone and surrounding tissues, then marks them with color-coded overlays on the two-dimensional B-mode image. The overlays leave the original anatomical data unchanged and visible underneath, and an on-screen three-dimensional indicator shows the scan’s orientation and where the displayed slice sits within the...

In this episode of Curing with Sound, we speak with Jeffrey Coull, PhD, founder and CEO of Grey Matter Neurosciences, a Toronto-based company developing low-intensity focused ultrasound technology for targeted brain neuromodulation. Building on research led by Dr. Kullervo Hynynen and his team at Sunnybrook Research Institute, the company’s helmet-based system uses an array of more than 2,000 ultrasound transmitters to reach both superficial and deep brain structures. Dr. Coull discusses why the company chose treatment-resistant depression as its initial clinical application, while also...

Expanding use of a non-invasive, ultrasound-based cancer treatment is the ultimate goal of the new University of Michigan Histotripsy Center, a first-of-its-kind facility launched Sept. 10.

YouTube video by My little retro computer world